0001437749-24-000756.txt : 20240105
0001437749-24-000756.hdr.sgml : 20240105
20240105170059
ACCESSION NUMBER: 0001437749-24-000756
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240103
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Power Sean A
CENTRAL INDEX KEY: 0001538845
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32639
FILM NUMBER: 24517376
MAIL ADDRESS:
STREET 1: 787 SEVENTH AVENUE, 48TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TG THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001001316
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 363898269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: (212) 554-4484
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030310
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC
DATE OF NAME CHANGE: 20000330
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960703
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-01-03
0001001316
TG THERAPEUTICS, INC.
TGTX
0001538845
Power Sean A
3020 CARRINGTON MILL BLVD
SUITE 475
MORRISVILLE
NC
27560
1
CFO
0
Common Stock
2024-01-03
4
S
0
47867
16.91
D
606969
D
Common Stock
2024-01-05
4
A
0
75000
0
A
681969
D
In connection with the vesting of 95,000 shares on January 1, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Includes shares of restricted Common Stock, which vest over various time periods.
Reflects a grant of restricted shares, of which 1/4 will vest on 1/1/2025, 1/4 will vest on 1/1/2026, 1/4 will vest on 1/1/2027, and 1/4 will vest on 1/1/2028.
/s/ Sean A. Power
2024-01-05